Harmony Biosciences · 9 hours ago
Summer Intern - IT Security
Harmony Biosciences specializes in developing treatments for rare neurological diseases and is seeking a Summer Intern for their IT Security team. This position will assist in various projects related to information security and support the IT security Manager in managing Harmony’s information security program.
BiopharmaBiotechnologyHealth Care
Responsibilities
Aid in the review and update of documentation for policies, procedures, standards and guidelines
Research and evaluate applications and services for use by Harmony. Provide a matrix, detailing features within each different application or service
Assistance with the deployment and upkeep of the information security department’s website content as part of the IT intranet site
Aid in the Pentest of internal and external sites
Partner with business teams in developing the table top scenarios and align with the Harmony IT team in designing the solution
Assist with SSO for specific applications, services, networks and servers as required
Under the guidance of the CIO and the security manager, list compliance tasks against accepted security controls by partnering with the Compliance team
Work internally with the Security manager and external security consultant in drafting the security roadmap and plan
Other duties as assigned
Qualification
Required
Minimum age for all candidates must be at least 18 years or older
Must be enrolled in an accredited college or university as a rising sophomore, junior or senior
Must be proficient in use of MS Excel, MS Power Point, MS Teams
Demonstrated interpersonal skills including flexibility, collaboration and inclusion skills, and ability to work in a team environment
Candidates must have strong written and verbal communication skills
Company
Harmony Biosciences
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Funding
Current Stage
Public CompanyTotal Funding
$1.68BKey Investors
Blackstone Life SciencesBlackstone GroupOrbiMed
2024-10-30Post Ipo Secondary· $248M
2023-07-27Post Ipo Debt· $185M
2021-11-01Post Ipo Equity· $200M
Leadership Team
Recent News
2026-01-13
Bizjournals.com Feed (2025-11-12 15:43:17)
2026-01-13
Company data provided by crunchbase